Giuliana Santoro
Medical · North Miami Beach, FLNPI 1619450681
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.5% of the total across 167 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 41 manufacturers, the largest accounting for just 23.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,427, more than ten times the $69 reported in 2021.
Across 167 payments — averaging $21.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$844
- AstraZeneca$295
- Daiichi Sankyo Inc.$295
- Genentech USA, Inc.$250
- AbbVie$200
- Tersera Therapeutics LLC$180
- plus $2K from 35 others
What the payments were for
- Food & beverage$3,40094%
- Education$1996%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 44 | $844 |
| AstraZeneca | 9 | $295 |
| Daiichi Sankyo Inc. | 14 | $295 |
| Genentech USA, Inc. | 11 | $250 |
| AbbVie | 8 | $200 |
| Tersera Therapeutics LLC | 7 | $180 |
| Novartis | 8 | $134 |
| Merck | 6 | $106 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $104 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Immunocore Limited | 3 | $73 |
| Pfizer | 3 | $73 |
| Eisai Inc. | 4 | $68 |
| Incyte Corporation | 3 | $65 |
| Sanofi | 3 | $60 |
| Beone Medicines USA, Inc. | 3 | $59 |
| Jazz Pharmaceuticals Inc. | 3 | $48 |
| Seagen Inc. | 2 | $44 |
| Immunogen, Inc. | 2 | $44 |
| Astellas Pharma US Inc | 2 | $41 |
| Boehringer Ingelheim | 2 | $40 |
| GSK | 2 | $38 |
| Sun Pharmaceutical Industries Inc. | 2 | $37 |
| Taiho Oncology, Inc. | 2 | $35 |
| Coherus Oncology, Inc. | 2 | $34 |
| Stemline Therapeutics Inc. | 1 | $28 |
| Foundation Medicine, Inc. | 1 | $26 |
| Servier Pharmaceuticals LLC | 1 | $25 |
| Lilly USA, LLC | 1 | $25 |
| AVEO Pharmaceuticals, Inc. | 1 | $25 |
| Sobi, Inc | 1 | $24 |
| Acrotech Biopharma Inc. | 1 | $23 |
| Bayer | 1 | $23 |
| Beigene USA, Inc. | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Genmab U.S., Inc. | 1 | $19 |
| Exelixis Inc. | 1 | $18 |
| Ipsen Biopharmaceuticals, Inc | 1 | $17 |
| Puma Biotechnology, Inc. | 1 | $15 |
| Argenx US, Inc. | 1 | $15 |
| Alnylam Pharmaceuticals Inc. | 1 | $14 |
How this compares
$3,599 in reported general payments places this provider in the 80th percentile of 2,031 medical providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron Hcl | 14 | $47 |
Paid to pharmacies, not to this prescriber.
Other medical in North Miami Beach
- Amy MichaelsNorth Miami Beach$44K
- Gary RubinRockledge$2.1M
- Shanna MirantiNaples$415K
- Krystie LennoxBoca Raton$245K
- Jihan RamadanWellington$238K
- Ilanit SamuelsMiami$211K
- Erin DouceyWinter Haven$202K
- Kathleen TrummerWellington$166K
- Sandra SnyderTampa$156K
- Francine PhillipsLand O Lakes$145K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.